Meiogenix Announces $13 Million Series a Financing Round Led by Sofinnova Partners

Paris, France, Dec. 14, 2021 (GLOBE NEWSWIRE) — Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, announced today the closing of a $13 million (โ‚ฌ11 million) Series A financing round, led by Sofinnova Partners, with participation from Genoa Ventures, Bpifrance, Casdin Capital and Alexandria Venture Investments. Read More